These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15853647)

  • 21. A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.
    Aliagas-Martin I; Burdick D; Corson L; Dotson J; Drummond J; Fields C; Huang OW; Hunsaker T; Kleinheinz T; Krueger E; Liang J; Moffat J; Phillips G; Pulk R; Rawson TE; Ultsch M; Walker L; Wiesmann C; Zhang B; Zhu BY; Cochran AG
    J Med Chem; 2009 May; 52(10):3300-7. PubMed ID: 19402633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Target validation and biomarker identification in oncology : the example of aurora kinases.
    Colombo R; Moll J
    Mol Diagn Ther; 2008; 12(2):71-6. PubMed ID: 18422371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancer.
    Warner SL; Stephens BJ; Von Hoff DD
    Curr Oncol Rep; 2008 Mar; 10(2):122-9. PubMed ID: 18377825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aurora kinases and their inhibitors: more than one target and one drug.
    Carpinelli P; Moll J
    Adv Exp Med Biol; 2008; 610():54-73. PubMed ID: 18593015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aurora A: target invalidated?
    Cochran AG
    Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The serine/threonine kinases that control cell cycle progression as therapeutic targets].
    Diallo A; Prigent C
    Bull Cancer; 2011 Nov; 98(11):1335-45. PubMed ID: 22020767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of Aurora kinases in mitosis and tumorigenesis.
    Fu J; Bian M; Jiang Q; Zhang C
    Mol Cancer Res; 2007 Jan; 5(1):1-10. PubMed ID: 17259342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
    Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
    Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approach.
    Warner SL; Bashyam S; Vankayalapati H; Bearss DJ; Han H; Mahadevan D; Von Hoff DD; Hurley LH
    Mol Cancer Ther; 2006 Jul; 5(7):1764-73. PubMed ID: 16891462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of selective aminothiazole aurora kinase inhibitors.
    Andersen CB; Wan Y; Chang JW; Riggs B; Lee C; Liu Y; Sessa F; Villa F; Kwiatkowski N; Suzuki M; Nallan L; Heald R; Musacchio A; Gray NS
    ACS Chem Biol; 2008 Mar; 3(3):180-92. PubMed ID: 18307303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aurora kinases dawn as cancer drug targets.
    Sausville EA
    Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
    [No Abstract]   [Full Text] [Related]  

  • 33. Aurora kinase inhibitors: a new class of targeted drugs in cancer.
    Gautschi O; Mack PC; Davies AM; Lara PN; Gandara DR
    Clin Lung Cancer; 2006 Sep; 8(2):93-8. PubMed ID: 17026809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in Aurora kinase inhibitor patents.
    Coumar MS; Cheung CH; Chang JY; Hsieh HP
    Expert Opin Ther Pat; 2009 Mar; 19(3):321-56. PubMed ID: 19441907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurora A and B kinases--targets of novel anticancer drugs.
    Libertini S; Abagnale A; Passaro C; Botta G; Portella G
    Recent Pat Anticancer Drug Discov; 2010 Nov; 5(3):219-41. PubMed ID: 20524930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.
    Walsby E; Walsh V; Pepper C; Burnett A; Mills K
    Haematologica; 2008 May; 93(5):662-9. PubMed ID: 18367484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora kinase inhibitors: progress towards the clinic.
    Kollareddy M; Zheleva D; Dzubak P; Brahmkshatriya PS; Lepsik M; Hajduch M
    Invest New Drugs; 2012 Dec; 30(6):2411-32. PubMed ID: 22350019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aurora kinases: structure, functions and their association with cancer.
    Kollareddy M; Dzubak P; Zheleva D; Hajduch M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):27-33. PubMed ID: 18795071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora kinase inhibitors as anti-cancer therapy.
    Lok W; Klein RQ; Saif MW
    Anticancer Drugs; 2010 Apr; 21(4):339-50. PubMed ID: 20016367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aurora kinase inhibitors--rising stars in cancer therapeutics?
    Dar AA; Goff LW; Majid S; Berlin J; El-Rifai W
    Mol Cancer Ther; 2010 Feb; 9(2):268-78. PubMed ID: 20124450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.